BR9912816A - Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos - Google Patents
Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicosInfo
- Publication number
- BR9912816A BR9912816A BR9912816-0A BR9912816A BR9912816A BR 9912816 A BR9912816 A BR 9912816A BR 9912816 A BR9912816 A BR 9912816A BR 9912816 A BR9912816 A BR 9912816A
- Authority
- BR
- Brazil
- Prior art keywords
- tumors
- treatment
- intended
- flavonoids
- cytotoxic agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçãO TERAPêUTICA à BASE DE FLAVONóIDES, TENCIONADA PARA USO NO TRATAMENTO DE TUMORES POR AGENTES CITOTóXICOS"<D>. A presente invenção refere-se a composição tendo uma atividade sobre a proliferação de células clonogênicas em tumores e compreendendo uma quantidade terapeuticamente eficaz de um flavonóide, em particular um composto selecionado entre os compostos de fórmula (I) em que; R~ 1~, R~ 2~, R~ 3~ e R~ 4~, R~ 5~ e R~ 6~ são conforme definidos na reivindicação 2. A composição referida é planejada para uso no tratamento de tumores com agentes citotóxicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9809058A FR2781153B1 (fr) | 1998-07-15 | 1998-07-15 | Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
PCT/FR1999/001714 WO2000003706A1 (fr) | 1998-07-15 | 1999-07-13 | Composition therapeutique a base de flavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9912816A true BR9912816A (pt) | 2001-05-08 |
Family
ID=9528648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9912816-0A BR9912816A (pt) | 1998-07-15 | 1999-07-13 | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1096930A1 (pt) |
JP (1) | JP2002520356A (pt) |
KR (1) | KR20020003349A (pt) |
CN (1) | CN1139384C (pt) |
AU (1) | AU4789099A (pt) |
BR (1) | BR9912816A (pt) |
CA (1) | CA2337179A1 (pt) |
EA (1) | EA200100140A1 (pt) |
FR (1) | FR2781153B1 (pt) |
IL (1) | IL140588A0 (pt) |
WO (1) | WO2000003706A1 (pt) |
ZA (1) | ZA200100239B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002069949A2 (en) * | 2001-03-06 | 2002-09-12 | Prendergast Patrick T | Combination therapy for reduction of toxycity of chemotherapeutic agents |
EP1808172A3 (en) * | 2002-03-06 | 2010-05-26 | Activephyto Technologies Limited | Botanical extract compositions and methods of use |
WO2003075943A2 (en) * | 2002-03-06 | 2003-09-18 | The Medical Research And Education Trust | Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol |
US20030229136A1 (en) * | 2002-04-18 | 2003-12-11 | Nurulain Zaveri | Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
CN1679539A (zh) * | 2005-01-20 | 2005-10-12 | 吴一心 | 抗肿瘤的协同药物组合物 |
JP2008533039A (ja) * | 2005-03-11 | 2008-08-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 抗アポトーシスBcl−2ファミリーメンバーのクロメン−4−オン阻害剤およびその使用 |
GB0808974D0 (en) * | 2008-05-16 | 2008-06-25 | Veritron Ltd | Plant extract and its therapeutic use |
US9808439B2 (en) * | 2015-07-29 | 2017-11-07 | Macau University Of Science And Technology | Use of tangeretin in cancer treatment |
US9808477B2 (en) * | 2015-07-29 | 2017-11-07 | Macau University Of Science And Technology | Use of nobiletin in cancer treatment |
JP6775226B2 (ja) * | 2016-06-30 | 2020-10-28 | 国立大学法人広島大学 | 抗癌剤作用増強物質およびそれを備えた抗癌剤キット |
CN106562954A (zh) * | 2016-11-11 | 2017-04-19 | 黄冈师范学院 | (去甲基)多甲氧基黄酮联合紫杉醇类药物在制备治疗非小细胞肺癌的药物上的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0617304B2 (ja) * | 1982-09-09 | 1994-03-09 | 理化学研究所 | 制癌剤 |
JPS5959627A (ja) * | 1982-09-27 | 1984-04-05 | Tatsuo Miyoshi | 制癌剤 |
JPS60199817A (ja) * | 1984-03-23 | 1985-10-09 | Rikagaku Kenkyusho | 制癌剤 |
JPS632925A (ja) * | 1986-06-23 | 1988-01-07 | Nippon Kayaku Co Ltd | Cキナ−ゼ阻害剤および抗腫瘍剤 |
FR2633182B1 (fr) * | 1988-06-23 | 1993-07-23 | Beljanski Mirko | Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention |
JPH04103532A (ja) * | 1990-08-24 | 1992-04-06 | Tatsuo Miyoshi | 制癌剤 |
JPH04103529A (ja) * | 1990-08-24 | 1992-04-06 | Tatsuo Miyoshi | 制癌剤 |
JP2514500B2 (ja) * | 1991-09-14 | 1996-07-10 | 呉羽化学工業株式会社 | 多剤耐性抑制剤及び発現阻害剤 |
EP0642793A4 (en) * | 1992-05-11 | 1995-03-29 | Tsumura & Co. | Apoptosis inducer. |
WO1996031206A2 (en) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
DE29719198U1 (de) * | 1997-10-29 | 1998-04-23 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, 14558 Bergholz-Rehbrücke | Flavono/Flavonoid-Zubereitung |
-
1998
- 1998-07-15 FR FR9809058A patent/FR2781153B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-13 CA CA002337179A patent/CA2337179A1/en not_active Abandoned
- 1999-07-13 JP JP2000559841A patent/JP2002520356A/ja active Pending
- 1999-07-13 WO PCT/FR1999/001714 patent/WO2000003706A1/fr not_active Application Discontinuation
- 1999-07-13 EP EP99931342A patent/EP1096930A1/fr not_active Withdrawn
- 1999-07-13 EA EA200100140A patent/EA200100140A1/ru unknown
- 1999-07-13 CN CNB998098353A patent/CN1139384C/zh not_active Expired - Fee Related
- 1999-07-13 KR KR1020017000478A patent/KR20020003349A/ko not_active Application Discontinuation
- 1999-07-13 AU AU47890/99A patent/AU4789099A/en not_active Abandoned
- 1999-07-13 IL IL14058899A patent/IL140588A0/xx unknown
- 1999-07-13 BR BR9912816-0A patent/BR9912816A/pt not_active IP Right Cessation
-
2001
- 2001-01-09 ZA ZA200100239A patent/ZA200100239B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1139384C (zh) | 2004-02-25 |
WO2000003706A1 (fr) | 2000-01-27 |
JP2002520356A (ja) | 2002-07-09 |
AU4789099A (en) | 2000-02-07 |
FR2781153B1 (fr) | 2001-08-03 |
FR2781153A1 (fr) | 2000-01-21 |
EP1096930A1 (fr) | 2001-05-09 |
KR20020003349A (ko) | 2002-01-12 |
EA200100140A1 (ru) | 2001-06-25 |
CA2337179A1 (en) | 2000-01-27 |
CN1313765A (zh) | 2001-09-19 |
IL140588A0 (en) | 2002-02-10 |
ZA200100239B (en) | 2002-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
ECSP003682A (es) | Compuestos para el tratamiento de la isquemia | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR9912073A (pt) | Composições farmacêuticas que compreendem 2-quinolonas | |
BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
BR0209127A (pt) | compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
BR0008840A (pt) | Derivados de camptotecina tendo atividade antitumoral | |
BRPI0111639B8 (pt) | uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica. | |
ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
BRPI0311323B8 (pt) | composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação | |
BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
ES2149305T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y procedimientos de uso. | |
BRPI0415713A (pt) | mio-inositol hexafosfato para uso tópico | |
BR9912816A (pt) | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
BR9916422A (pt) | Saponinas antiprotozoárias | |
BRPI0417161A (pt) | compostos, composições farmacêuticas, e, uso de um composto | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
BR0208405A (pt) | Compostos de diidropirimina substituìdos com ciano e seu uso para tratar doenças |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A, 8A E 9A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |